NeuroPace (NPCE) Long-Term Deferred Tax (2020 - 2024)
NeuroPace's (NPCE) quarterly Long-Term Deferred Tax came in at $300000.0 in Q4 2024, down 25.0% year-on-year from $400000.0 in Q1 2024, and up 4.17% quarter-over-quarter from $288000.0 in Q3 2024.
NeuroPace (NPCE) Long-Term Deferred Tax (2020 - 2024) Analysis & Trends
NeuroPace's Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $300000.0 for Q4 2024.
- On a quarterly basis, Long-Term Deferred Tax fell 25.0% year-over-year to $300000.0 in Q4 2024; TTM through Dec 2024 was $300000.0, a 25.0% decrease from a year earlier, with the FY2024 full-year figure at $300000.0, down 25.0% from the prior year.
- Long-Term Deferred Tax rose to $300000.0 in Q4 2024 per NPCE's latest filing, from $288000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $2.4 million in Q1 2021 and bottomed at $288000.0 in Q3 2024.
- The 5-year median for Long-Term Deferred Tax is $400000.0 (2023), against an average of $580181.8.
- Across the five-year window, Long-Term Deferred Tax grew 15.27% in 2023 and plunged 38.2% in 2024, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $484000.0 in 2020, then jumped by 395.87% to $2.4 million in 2021, then sank by 85.54% to $347000.0 in 2022, then grew by 15.27% to $400000.0 in 2023, then decreased by 25.0% to $300000.0 in 2024.
- Per Business Quant, the three latest NPCE Long-Term Deferred Tax figures stand at $300000.0 (Q4 2024), $288000.0 (Q3 2024), and $387000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 288,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 387,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 466,000.00 |
| Jun 30, 2023 | 466,000.00 |
| Mar 31, 2023 | 457,000.00 |
| Dec 31, 2022 | 347,000.00 |
| Mar 31, 2021 | 2.40 Mn |
| Dec 31, 2020 | 484,000.00 |